Astepro Related Published Studies
Well-designed clinical trials related to Astepro (Azelastine)
MP29-02 (a novel intranasal formulation of azelastine hydrochloride and
fluticasone propionate) in the treatment of seasonal allergic rhinitis: a
randomized, double-blind, placebo-controlled trial of efficacy and safety. [2012]
Double-blind, placebo-controlled study of azelastine and fluticasone in a single
nasal spray delivery device. [2010]
Double-blind, placebo-controlled trial of reformulated azelastine nasal spray in
patients with seasonal allergic rhinitis. [2009]
Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal
spray in patients with seasonal allergic rhinitis. [2009]
The effects of the nasal antihistamines olopatadine and azelastine in nasal
allergen provocation. [2008]
Impact of azelastine nasal spray on symptoms and quality of life compared with
cetirizine oral tablets in patients with seasonal allergic rhinitis. [2006]
Effectiveness of azelastine nasal spray compared with oral cetirizine in patients
with seasonal allergic rhinitis. [2005]
Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who
remain symptomatic after treatment with fexofenadine. [2004]
Histamine skin test reactivity following single and multiple doses of azelastine
nasal spray in patients with seasonal allergic rhinitis. [2003]
Efficacy of azelastine nasal spray in patients with an unsatisfactory response to
loratadine. [2003]
Topical azelastine in perennial allergic conjunctivitis. [2003]
Comparison of the efficacy and tolerability of topically administered azelastine, sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis and rhino-conjunctivitis. [2003]
Rapid anti-inflammatory action of azelastine eyedrops for ongoing allergic
reactions. [2003]
Azelastine eye drops in the treatment of perennial allergic conjunctivitis. [2003]
Effects of intranasal azelastine on the response to nasal allergen challenge. [2002]
Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution
and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival
allergen challenge model. [2001]
Treatment of severe seasonal rhinoconjunctivitis by a combination of azelastine nasal spray and eye drops: a double-blind, double-placebo study. [2001]
Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis. [2001]
Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial
nonallergic) rhinitis. [2001]
Comparison of azelastine eye drops with levocabastine eye drops in the treatment of seasonal allergic conjunctivitis. [2000]
Evaluation of the onset and duration of effect of azelastine eye drops (0.05%)
versus placebo in patients with allergic conjunctivitis using an allergen
challenge model. [2000]
Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and
daytime somnolence in perennial allergic rhinitis. [2000]
Double-blind trials of azelastine nasal spray monotherapy versus combination
therapy with loratadine tablets and beclomethasone nasal spray in patients with
seasonal allergic rhinitis. Rhinitis Study Groups. [1999]
Histamine and tryptase in nasal lavage fluid after allergen challenge: effect of
1 week of pretreatment with intranasal azelastine or systemic cetirizine. [1999]
Azelastine eye drops reduce conjunctival hyperresponsiveness to hyperosmolar
glucose challenge in children with asymptomatic mite conjunctivitis. [1999]
[Clinical assessment of azelastine nasal spray in seasonal allergic rhinitis]. [Article in Polish] [1998]
Nasal budesonide offers superior symptom relief in perennial allergic rhinitis in
comparison to nasal azelastine. [1998]
Azelastine eye drops in the treatment of seasonal allergic conjunctivitis or rhinoconjunctivitis in young children. [1998]
The effect of azelastine on the infiltration of inflammatory cells into the
bronchial mucosa and clinical changes in patients with bronchial asthma. [1997]
Azelastine nasal spray as adjunctive therapy to azelastine tablets in the
management of seasonal allergic rhinitis. [1997]
Seasonal rhinitis and azelastine: long- or short-term treatment? [1997]
Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert
anti-allergic activity. [1997]
Double-blind, randomised, placebo-controlled study of two concentrations of azelastine eye drops in seasonal allergic conjunctivitis or rhinoconjunctivitis. [1997]
Well-designed clinical trials possibly related to Astepro (Azelastine)
Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination
with an intranasal corticosteroid in seasonal allergic rhinitis. [2010]
A comparison of intranasal corticosteroid, leukotriene receptor antagonist, and
topical antihistamine in reducing symptoms of perennial allergic rhinitis as
assessed through the Rhinitis Severity Score. [2010]
Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of
seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind,
active- and placebo-controlled study in adolescents and adults. [2009]
A novel and effective approach to treating rhinitis with nasal antihistamines. [2007]
Verteporfin : a review of its use in the management of subfoveal choroidal neovascularisation. [2003]
Efficacy of a steroid nasal spray compared with an antihistamine nasal spray in
the treatment of perennial allergic rhinitis. [2000]
Differential effects of new-generation H1-receptor antagonists in pruritic
dermatoses. [1998]
Worldwide clinical experience with the first marketed leukotriene receptor
antagonist. [1997]
Other research related to Astepro (Azelastine)
Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of
azelastine hydrochloride and fluticasone propionate in an advanced delivery
system) in subjects with chronic rhinitis. [2014]
Intranasal phototherapy versus azelastine in the treatment of seasonal allergic
rhinitis. [2013]
A multicenter randomized double-blind 2-week comparison study of azelastine nasal spray 0.1% versus levocabastine nasal spray 0.05% in patients with moderate-to-severe allergic rhinitis. [2011]
Comparison of azelastine versus triamcinolone nasal spray in allergic and
nonallergic rhinitis. [2010]
Other possibly related research studies
Solubilized nasal steroid (CDX-947) when combined in the same solution nasal
spray with an antihistamine (CDX-313) provides improved, fast-acting symptom
relief in patients with allergic rhinitis. [2011]
[Effect of penetrating needling at head acupoints on perennial allergic
rhinitis]. [Article in Chinese] [2013]
|
